<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="1032">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on October 07, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04371744</url>
  </required_header>
  <id_info>
    <org_study_id>CIL 2020-52</org_study_id>
    <nct_id>NCT04371744</nct_id>
  </id_info>
  <brief_title>QT-Logs : Artificial Intelligence for QT Interval Analysis of ECG From Smartwatches in Patient Receiving Treatment for Covid-19</brief_title>
  <acronym>QT-Logs</acronym>
  <official_title>QT-Logs : a Clinical Study to Monitor Cardiac Safety, With Artificial Intelligence for QT Interval Analysis of ECG Data From Smartwatches, in Patients Receiving Hydroxychloroquine Treatment for COVID-19</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique Hopitaux De Marseille</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assistance Publique Hopitaux De Marseille</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This observational pilot prospective study will evaluate a new method for remote monitoring
      of corrected QT measurement using an artificial intelligence (AI)-based solution and ECG data
      collected via smartwatches (AI-QTc), in patients ambulatory treated with the HC-AZ
      combination, at the early stage of COVID-19 infection, at a tertiary hospital center. Daily
      ECGs will be performed via the smartwatches. AI-QTc will be compared to standard manual QTc
      reviewed by cardiologist. Correlation and agreement between measures will be assessed.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 17, 2020</start_date>
  <completion_date type="Actual">June 5, 2020</completion_date>
  <primary_completion_date type="Actual">June 4, 2020</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>10 Days</target_duration>
  <primary_outcome>
    <measure>Corrected QT (QTc) interval measurement</measure>
    <time_frame>10 days</time_frame>
    <description>Measurement of QTc using an artificial intelligence (AI)-based solution and ECG data collected via smartwatches, compare to standard 12 leads ECG reviewed by cardiologist</description>
  </primary_outcome>
  <enrollment type="Actual">100</enrollment>
  <condition>COVID-19</condition>
  <eligibility>
    <study_pop>
      <textblock>
        100 consecutives patients ambulatory treated with the Hydroxychloroquine and Azythromycine
        combination, at the early stage of COVID-19 infection for 10 days, at the university
        hospital of La Timone, in Marseille
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient over 18 years old

          -  SARS-COV-2 confirmed infection by positive nasopharyngual PCR

          -  Prescription of association hydroxychloroquine and azythromycine for COVI-19 therapy

          -  Patient's smartphone able to download the smartwatches application

        Exclusion Criteria:

          -  Presence of a pacemaker

          -  Pregnant or breastfeeding females

          -  Refusal to participate

          -  Incapacity

          -  Adult under legal protection (trusteeship, guardianship)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Assistance Publique HÃ´pitaux de Marseille</name>
      <address>
        <city>Marseille</city>
        <zip>13005</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>April 30, 2020</study_first_submitted>
  <study_first_submitted_qc>April 30, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">May 1, 2020</study_first_posted>
  <last_update_submitted>June 5, 2020</last_update_submitted>
  <last_update_submitted_qc>June 5, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 9, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

